-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JolWh0J2lidWVvF4aDbrL8yljNFlSPouPwPlI/UJaPLHDfPWZmSrK2FtRN0tWV8r syprgdRKhAEZYDPlm0XwdA== 0000914190-10-000308.txt : 20100426 0000914190-10-000308.hdr.sgml : 20100426 20100426142523 ACCESSION NUMBER: 0000914190-10-000308 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20100422 FILED AS OF DATE: 20100426 DATE AS OF CHANGE: 20100426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Nile Therapeutics, Inc. CENTRAL INDEX KEY: 0001133869 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4 WEST 4TH AVE STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: (415) 875-7880 MAIL ADDRESS: STREET 1: 4 WEST 4TH AVE STREET 2: SUITE 400 CITY: SAN MATEO STATE: CA ZIP: 94402 FORMER COMPANY: FORMER CONFORMED NAME: SMI PRODUCTS INC DATE OF NAME CHANGE: 20010206 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kazam Joshua A CENTRAL INDEX KEY: 0001221355 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-34058 FILM NUMBER: 10770005 MAIL ADDRESS: STREET 1: 787 7TH AVE STREET 2: 48TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHUA A DATE OF NAME CHANGE: 20070920 FORMER NAME: FORMER CONFORMED NAME: KAZAM JOSHOA A DATE OF NAME CHANGE: 20030303 4 1 edgar.xml PRIMARY DOCUMENT X0303 4 2010-04-22 0001133869 Nile Therapeutics, Inc. NLTX 0001221355 Kazam Joshua A C/O TWO RIVER GROUP HOLDINGS, LLC 689 FIFTH AVENUE, 12TH FLOOR NEW YORK NY 10022 1 1 0 0 Chief Executive Officer Common Stock 2010-04-22 4 P 0 50000 A 1328228 D Common Stock 613841 I By Kazam Family Trust Common Stock 165530 I By Spouse for Minor Child Common Stock 165530 I By Kash Family Foundation Stock Option (Right to Buy) 4.50 2018-01-25 Common Stock 50000 50000 D Stock Option (Right to Buy) .93 2010-01-01 2018-12-22 Common Stock 25000 25000 D Warrant (Right to Buy) 1.25 2009-07-07 2014-07-07 Common Stock 49407 49407 D Warrant (Right to Buy) 1.71 2009-07-07 2014-07-07 Common Stock 49407 49407 D Warrant (Right to Buy) 2.28 2009-07-07 2014-07-07 Common Stock 98814 98814 D Warrant (Right to Buy) 1.375 2009-07-15 2019-07-15 Common Stock 31650 31650 D Stock Option (Right to Buy) 1.77 2010-07-21 2019-07-21 Common Stock 65000 65000 D Warrant (Right to Buy) .94 2010-04-22 4 P 0 15000 A 2010-04-27 2015-04-21 Common Stock 15000 15000 D The reported securities were part of a unit purchase by the Reporting Person at a price of $0.70 per unit, with each unit consisting of one share of common stock and 0.30 warrants to purchase common stock. Held by Reporting Person's spouse as custodian for the benefit of their minor child under the Uniform Gift to Minors Act. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary intrest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of these shares for purposes of Section 16 or any other purpose. The Reporting Person is the Trustee of the Kash Family Foundation and controls the right to vote and dispose of the shares held by the Trust. However, the Reporting Person has no pecuniary interest in the shares held by the Foundation. The shares subject to the option vest in three equal installments on September 17, 2008, September 17, 2009 and September 17, 2010. /s/ Daron Evans as Attorney-in-Fact for Joshua A. Kazam pursuant to Power of Attorney previously filed. 2010-04-26 -----END PRIVACY-ENHANCED MESSAGE-----